Ultra high molecular weight polyethylene (UHMWPE) was introduced into clinical practice by Charnley in November 1962 and has remained the standard material for the hip and other total joint arthroplasties. Wear of the UHMWPE cup, although studied from the beginning, did not appear to be a clinical problem although Charnley suspected that this would be so in the long term. A review of the outcome of the
Introduction: We previously reported our results of 98
Total hip replacement is a successful and reliable procedure for the relief of pain, but the results achieved have been reported to be less successful in younger patients who tend to be relatively more active and place greater demands on prostheses than older patients. Between 1966 and 1978, 226 Charnley low friction arthroplasties (LFAs) were implanted in young patients with an average age at operation of 31.7 years. Initial results were presented at an average of 19.7 years. We have performed a further retrospective analysis of this cohort at 10 years on from the time of data collection of the original study. Of the original cohort, 112 patients are alive and either under follow-up at our hospital or have been traced to other hospitals. 16 have been lost to follow-up. Mean follow-up was 26.4 years. At the time of final follow-up or death, rate of aseptic loosening of the stem was approximately 80%. Acetabular components proved to be less successful with less than 60% remaining well fixed. Differences in survival were apparent between subgroups with differing original pathology with stem survival greater in those with DDH as opposed to rheumatoid or degenerative arthritis and the opposite being true for socket survival. This study adds to the available knowledge of the longevity of cemented total hip replacement as performed with unsophisticated cementation techniques and how it may perform in differing patients groups.
Eleven patients (3%) had one or more episodes of dislocation. There were 22 revisions. Three of the revisions were carried out for infection, and a further 2 for recurrent dislocation. Aseptic loosening was the cause of failure in the remaining 17. Thirty three patients (36 hips, 9%) could not be traced at the time of the final follow-up. There was significant and maintained improvement in pain and function scores. One hundred and thirty eight patients (146 hips) had died at the time of the final follow-up. The best and worst case survivorship figures at 10 years were 93 +/− 2% and 83 +/− 2%, and those at 14 years were 88 +/− 4% and 78 +/− 4%, respectively, with revision for any reason as the end-point.
Introduction and Aims: We present the results of 228 consecutive
Since wear and loosening of the ultra high molecular weight polyethylene is the one factor limiting the life of the arthroplasty we set out to identify factors associated with either low wear 0.02 mm/year or less, or high wear 0.2 mm/year or more. In a group of 1092 patients, 1434
A prospective study of Charnley low friction arthroplasty in patients under the age of 51 at the time of surgery. 1092 patients, 668 women and 424 men, mean age 41 years (12–51) at the time of surgery had 1434
Purpose of the study: Long-term outcome of